Vertex, Inc. provides tax calculation and compliance software to companies worldwide. The company has produced top line revenue growth, but operating results are turning negative.

For the full year 2025, Vertex expects revenue of $760-768 million, in line with the $764 million consensus estimate. "Vertex’s 2024 financial results demonstrated the power of our business and ...

Vertex's third-quarter revenue of $170.4 million marked a 17.5% year-over-year increase, primarily driven by a rise in software subscription and cloud revenue, which grew by 28.5%. The company's ...

Vertex Pharmaceuticals (NASDAQ:VRTX) missed on the top and bottom lines in its Q1 financial results and also raised the low end of its full-year total revenue range. The drugmaker best known for ...

Vertex (VRTX) stock was trading largely flat post-market after the company released its Q4 earnings report and issued 2025 guidance that was largely in line with Street estimates.

Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) were trading largely flat post-market Monday after the biotech company released its Q4 earnings report and issued 2025 guidance that was largely in ...